• Consensus Rating: Buy
  • Consensus Price Target: $137.67
  • Forecasted Upside: 77.59 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$77.52
▲ +0.77 (1.00%)

This chart shows the closing price for MODV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ModivCare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MODV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MODV

Analyst Price Target is $137.67
▲ +77.59% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for ModivCare in the last 3 months. The average price target is $137.67, with a high forecast of $145.00 and a low forecast of $130.00. The average price target represents a 77.59% upside from the last price of $77.52.

This chart shows the closing price for MODV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in ModivCare.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/9/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/7/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/5/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/4/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/4/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/4/2022Barrington ResearchLower TargetOutperform$157.00 ➝ $138.00Low
8/9/2022Barrington ResearchBoost Target$157.00Low
8/3/2022StephensReiterated RatingInitiatesLow
8/2/2022StephensInitiated CoverageOverweight$145.00Low
5/6/2022Deutsche Bank AktiengesellschaftLower Target$150.00 ➝ $130.00Medium
2/28/2022Barrington ResearchLower TargetOutperform$190.00 ➝ $155.00Medium
2/3/2022Deutsche Bank AktiengesellschaftLower TargetBuy$180.00 ➝ $150.00High
12/17/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$180.00High
8/4/2021Barrington ResearchBoost TargetOutperform$170.00 ➝ $186.00Low
7/27/2021Barrington ResearchReiterated RatingBuy$170.00High
5/10/2021Barrington ResearchBoost TargetOutperform$162.00 ➝ $170.00High
(Data available from 12/4/2017 forward)

News Sentiment Rating

-0.04 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/8/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/7/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2022
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/6/2022
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/5/2022
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2022
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/4/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
12/4/2022

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
ModivCare logo
ModivCare Inc., a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and patients. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and the Matrix Investment. The NEMT segment offers contact center management, network credentialing, claims management, and non-emergency medical transport management services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. The Personal Care segment provides bathing, personal hygiene, grooming, oral care, dressing, medication reminders, meal planning, preparation and feeding, housekeeping, transportation services, prescription reminders, and assistance with dressing and ambulation services through placing non-medical personal care assistants, home health aides, and skilled nurses primarily to Medicaid patients in need of care monitoring and assistance in performing daily living activities, including senior citizens and disabled adults. The RPM segment offers personal emergency response systems, vitals monitoring, medication management, and data-driven patient engagement solutions. The Matrix Investment segment provides in-home and on-site care services, as well as a fleet of mobile health clinics that offers community-based care with advanced diagnostic capabilities and care options. It serves federal, state, and local government agencies, MCOs, commercial insurers, private individuals, and health systems. The company was formerly known as The Providence Service Corporation and changed its name to ModivCare Inc. in January 2021. ModivCare Inc. was incorporated in 1996 and is headquartered in Denver, Colorado.
Read More

Today's Range

Now: $77.52
Low: $73.06
High: $77.96

50 Day Range

MA: $89.99
Low: $76.75
High: $102.85

52 Week Range

Now: $77.52
Low: $73.06
High: $154.31

Volume

88,382 shs

Average Volume

78,508 shs

Market Capitalization

$1.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Frequently Asked Questions

What sell-side analysts currently cover shares of ModivCare?

The following Wall Street analysts have issued stock ratings on ModivCare in the last twelve months: Barrington Research, Deutsche Bank Aktiengesellschaft, and Stephens.
View the latest analyst ratings for MODV.

What is the current price target for ModivCare?

3 Wall Street analysts have set twelve-month price targets for ModivCare in the last year. Their average twelve-month price target is $137.67, suggesting a possible upside of 77.6%. Stephens has the highest price target set, predicting MODV will reach $145.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $130.00 for ModivCare in the next year.
View the latest price targets for MODV.

What is the current consensus analyst rating for ModivCare?

ModivCare currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MODV will outperform the market and that investors should add to their positions of ModivCare.
View the latest ratings for MODV.

What other companies compete with ModivCare?

Other companies that are similar to ModivCare include Biohaven, Vericel, Alphatec, Deciphera Pharmaceuticals and Atrion. Learn More about companies similar to ModivCare.

How do I contact ModivCare's investor relations team?

ModivCare's physical mailing address is 1275 Peachtree Street Sixth Floor, Atlanta GA, 30309. The company's listed phone number is (303) 728-7030 and its investor relations email address is [email protected] The official website for ModivCare is www.modivcare.com. Learn More about contacing ModivCare investor relations.